Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Kraig Biocraft Laboratories (KBLB) Gains from Investment Securities (2017 - 2021)

Kraig Biocraft Laboratories (KBLB) has disclosed Gains from Investment Securities for 9 consecutive years, with -$79754.0 as the latest value for Q3 2021.

  • Quarterly Gains from Investment Securities changed N/A to -$79754.0 in Q3 2021 from the year-ago period, while the trailing twelve-month figure was -$49321.0 through Dec 2021, changed N/A year-over-year, with the annual reading at -$49321.0 for FY2021, N/A changed from the prior year.
  • Gains from Investment Securities hit -$79754.0 in Q3 2021 for Kraig Biocraft Laboratories, down from $19696.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $48.6 million in Q1 2017 to a low of -$79754.0 in Q3 2021.
  • Historically, Gains from Investment Securities has averaged $12.9 million across 3 years, with a median of $19696.0 in 2019.
  • Biggest YoY gain for Gains from Investment Securities was 709.17% in 2017; the steepest drop was 709.17% in 2017.
  • Year by year, Gains from Investment Securities stood at $15.8 million in 2017, then plummeted by 99.87% to $19696.0 in 2019, then crashed by 504.92% to -$79754.0 in 2021.
  • Business Quant data shows Gains from Investment Securities for KBLB at -$79754.0 in Q3 2021, $19696.0 in Q2 2019, and $10737.0 in Q1 2019.